USANA Health Sciences Files Definitive Proxy Statement
Ticker: USNA · Form: DEFA14A · Filed: 2025-04-09T00:00:00.000Z
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, shareholder-meeting
TL;DR
USANA filed its proxy statement, get ready to vote.
AI Summary
USANA Health Sciences, Inc. filed a Definitive Proxy Statement (DEFA14A) on April 9, 2025. This filing is related to the company's proxy materials, which are typically used for shareholder meetings to vote on corporate matters. The filing does not contain specific financial figures or details about upcoming votes but serves as official notification to shareholders.
Why It Matters
This filing is a standard regulatory requirement for public companies, informing shareholders about upcoming meetings and voting procedures. It ensures transparency in corporate governance.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEFA14A) and does not contain new financial information or strategic decisions that would inherently increase risk.
Key Players & Entities
- USANA HEALTH SCIENCES, INC. (company) — Registrant
- 0000896264-25-000111 (filing_id) — Accession Number
- 20250409 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for USANA Health Sciences, Inc.?
This is a Definitive Proxy Statement filed by USANA Health Sciences, Inc. under Section 14(a) of the Securities Exchange Act of 1934.
When was this DEFA14A filing submitted to the SEC?
The filing was submitted on April 9, 2025.
What is the purpose of a DEFA14A filing?
A DEFA14A filing is a proxy statement used by a company to solicit votes from its shareholders for an upcoming meeting.
Does this filing indicate any specific proposals or votes?
The provided text does not detail specific proposals or votes; it serves as the official proxy statement document.
What is the company's Central Index Key (CIK)?
The Central Index Key for USANA Health Sciences, Inc. is 0000896264.
From the Filing
0000896264-25-000111.txt : 20250409 0000896264-25-000111.hdr.sgml : 20250409 20250409123029 ACCESSION NUMBER: 0000896264-25-000111 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20250409 DATE AS OF CHANGE: 20250409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: USANA HEALTH SCIENCES INC CENTRAL INDEX KEY: 0000896264 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 870500306 STATE OF INCORPORATION: UT FISCAL YEAR END: 1228 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35024 FILM NUMBER: 25824469 BUSINESS ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 BUSINESS PHONE: 8019547100 MAIL ADDRESS: STREET 1: 3838 WEST PARKWAY BLVD. STREET 2: 3838 WEST PARKWAY BLVD. CITY: SALT LAKE CITY STATE: UT ZIP: 84120-6336 FORMER COMPANY: FORMER CONFORMED NAME: USANA INC DATE OF NAME CHANGE: 19930125 DEFA14A 1 defa14acombined.htm DEFA14A DEFA 14A Combined UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Mark One) x Filed by the Registrant o Filed by a Party other than the Registrant Check the appropriate box: o Preliminary Proxy Statement o Confidential, For use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Definitive Proxy Statement x Definitive Additional Materials o Soliciting Material Pursuant to § 240.14a-12 USANA HEALTH SCIENCES, INC. ______________________________ ( Name of Registrant as Specified in its Charter ) ______________________________ (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant) Payment of Filing Fee (Check the appropriate box) : x No fee required. o Fee paid previously with preliminary materials. o Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays as currently valid OMB control number. ___________________________________________________________________________________________________ Your Vote Counts! *Please check the meeting materials for any special requirements for meeting attendance. Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V67214-P26086 USANA HEALTH SCIENCES, INC. ATTN: JOSHUA FOUKAS 3838 W. PARKWAY BLVD. SALT LAKE CITY, UT 84120 USANA HEALTH SCIENCES, INC. You invested in USANA HEALTH SCIENCES, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on May 19, 2025. Vote Virtually at the Meeting* May 19, 2025 11:00 AM MDT Virtually at: www.virtualshareholdermeeting.com/USNA2025 Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 5, 2025. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. 2025 Annual Meeting Vote by May 18, 2025 11:59 PM ET. For shares held in a Plan, vote by May 14, 2025 11:59 PM ET. Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. Voting Items Board Recommends V67215-P26086 THIS IS NOT A VOTABLE BALLOT This is an overview of